Your shopping cart is currently empty

Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist for the study of migraine.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $158 | In Stock | In Stock | |
| 5 mg | $278 | In Stock | In Stock | |
| 10 mg | $347 | In Stock | In Stock | |
| 25 mg | $689 | In Stock | In Stock | |
| 50 mg | $1,230 | - | In Stock | |
| 100 mg | $1,790 | - | In Stock | |
| 200 mg | $2,420 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $372 | In Stock | In Stock |
| Description | Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist for the study of migraine. |
| Targets&IC50 | CGRP receptors (mouse):0.13 nM (Ki), CGRP receptors (rat):0.7 nM (Ki), CGRP receptors (rhesus macaque):0.009 nM (Ki), CGRP receptors (rabbit):2.1 nM (Ki), CGRP (human cloned):0.026 nM, CGRP receptors (human natural):0.026 nM (Ki), CGRP receptors (dog):1.2 nM (Ki), CGRP receptors (human cloned):0.015 nM (Ki) |
| In vitro | Atogepant has a CGRP IC50=0.026 nM for human clones. The binding affinities of Atogepant for human and non-human CGRP receptors were: human (cloned) Ki=0.015 nM, human (natural) Ki=0.026 nM, rhesus macaque Ki=0.009 nM, rat Ki=0.7 nM, mouse Ki=0.13 nM, rabbit Ki=2.1 nM, dog Ki=1.2 nM, respectively. [1][2] |
| In vivo | Oral administration of Atogepant to rats (at doses of 3, 10, and 30 mg/kg, respectively) once daily for 9 days showed that Atogepant effectively attenuated the abnormal facial pain induced by nitroglycerin and ameliorated the capsaicin-induced vasodilation of primate dermis in rats.[2] |
| Synonyms | MK8031. Atogepant, MK-8031, MK 8031, AGN-241689, AGN241689 |
| Molecular Weight | 603.52 |
| Formula | C29H23F6N5O3 |
| Cas No. | 1374248-81-3 |
| Smiles | O=C1[C@@]2(C=3C(N1)=NC=CC3)CC=4C(C2)=NC=C(C(N[C@H]5C[C@H]([C@@H](C)N(CC(F)(F)F)C5=O)C6=C(F)C(F)=CC=C6F)=O)C4 |
| Relative Density. | 1.54 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (132.56 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.